Gilead Provides Update on Phase 3 ASCENT-07 Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Gilead Sciences (NASDAQ: GILD) | Delayed: 159.20 +0.12 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $159.08 | 52 Week High | $108.63 | |||
| Open | $157.28 | 52 Week Low | $71.39 | |||
| Day High | $160.83 | P/E | 87.96 | |||
| Day Low | $156.04 | EPS | $1.81 | |||
| Volume | 4,993,742 | |||||
